Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1995 Mar 11;310(6980):637–640. doi: 10.1136/bmj.310.6980.637

Rheumatology.

A Bradlow 1, J David 1
PMCID: PMC2549012  PMID: 7703753

Full text

PDF
637

Images in this article

638FIG 2
on p.638
639FIG 3
on p.639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacons P. A., Kitas G. D. The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis. 1994 Oct;53(10):621–623. doi: 10.1136/ard.53.10.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bateman D. N. Tiaprofenic acid and cystitis. BMJ. 1994 Sep 3;309(6954):552–553. doi: 10.1136/bmj.309.6954.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blackburn W. D., Jr, Heck L. W., Loose L. D., Eskra J. D., Carty T. J. Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Feb;34(2):204–210. doi: 10.1002/art.1780340212. [DOI] [PubMed] [Google Scholar]
  4. Cash J. M., Klippel J. H. Second-line drug therapy for rheumatoid arthritis. N Engl J Med. 1994 May 12;330(19):1368–1375. doi: 10.1056/NEJM199405123301908. [DOI] [PubMed] [Google Scholar]
  5. Cooper C., Aihie A. Osteoporosis: recent advances in pathogenesis and treatment. Q J Med. 1994 Apr;87(4):203–209. [PubMed] [Google Scholar]
  6. Cope H., David A., Pelosi A., Mann A. Predictors of chronic "postviral" fatigue. Lancet. 1994 Sep 24;344(8926):864–868. doi: 10.1016/s0140-6736(94)92833-9. [DOI] [PubMed] [Google Scholar]
  7. Coste J., Delecoeuillerie G., Cohen de Lara A., Le Parc J. M., Paolaggi J. B. Clinical course and prognostic factors in acute low back pain: an inception cohort study in primary care practice. BMJ. 1994 Feb 26;308(6928):577–580. doi: 10.1136/bmj.308.6928.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deyo R. A. Magnetic resonance imaging of the lumbar spine. Terrific test or tar baby? N Engl J Med. 1994 Jul 14;331(2):115–116. doi: 10.1056/NEJM199407143310209. [DOI] [PubMed] [Google Scholar]
  9. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Bijl H., Woody J. N. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet. 1994 Oct 22;344(8930):1125–1127. doi: 10.1016/s0140-6736(94)90632-7. [DOI] [PubMed] [Google Scholar]
  10. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Katsikis P., Brennan F. M., Walker J., Bijl H., Ghrayeb J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993 Dec;36(12):1681–1690. doi: 10.1002/art.1780361206. [DOI] [PubMed] [Google Scholar]
  11. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  12. Gaston J. S. The role of infection in inflammatory arthritis. QJM. 1994 Nov;87(11):647–651. [PubMed] [Google Scholar]
  13. Gordon M., Luqmani R. A., Adu D., Greaves I., Richards N., Michael J., Emery P., Howie A. J., Bacon P. A. Relapses in patients with a systemic vasculitis. Q J Med. 1993 Dec;86(12):779–789. [PubMed] [Google Scholar]
  14. Gough A. K., Lilley J., Eyre S., Holder R. L., Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994 Jul 2;344(8914):23–27. doi: 10.1016/s0140-6736(94)91049-9. [DOI] [PubMed] [Google Scholar]
  15. Hill J., Bird H. A., Harmer R., Wright V., Lawton C. An evaluation of the effectiveness, safety and acceptability of a nurse practitioner in a rheumatology outpatient clinic. Br J Rheumatol. 1994 Mar;33(3):283–288. doi: 10.1093/rheumatology/33.3.283. [DOI] [PubMed] [Google Scholar]
  16. Isaacs J. D., Watts R. A., Hazleman B. L., Hale G., Keogan M. T., Cobbold S. P., Waldmann H. Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet. 1992 Sep 26;340(8822):748–752. doi: 10.1016/0140-6736(92)92294-p. [DOI] [PubMed] [Google Scholar]
  17. Jayson M. I. Mechanisms underlying chronic back pain. BMJ. 1994 Sep 17;309(6956):681–682. doi: 10.1136/bmj.309.6956.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jensen M. C., Brant-Zawadzki M. N., Obuchowski N., Modic M. T., Malkasian D., Ross J. S. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994 Jul 14;331(2):69–73. doi: 10.1056/NEJM199407143310201. [DOI] [PubMed] [Google Scholar]
  19. Johnston C. C., Jr, Slemenda C. W., Melton L. J., 3rd Clinical use of bone densitometry. N Engl J Med. 1991 Apr 18;324(16):1105–1109. doi: 10.1056/NEJM199104183241606. [DOI] [PubMed] [Google Scholar]
  20. Kremer J. M., Alarcón G. S., Lightfoot R. W., Jr, Willkens R. F., Furst D. E., Williams H. J., Dent P. B., Weinblatt M. E. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum. 1994 Mar;37(3):316–328. doi: 10.1002/art.1780370304. [DOI] [PubMed] [Google Scholar]
  21. Lambert C. M., Hurst N. P., Lochhead A., McGregor K., Hunter M., Forbes J. A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol. 1994 Apr;33(4):383–388. doi: 10.1093/rheumatology/33.4.383. [DOI] [PubMed] [Google Scholar]
  22. Landewé R. B., Goei Thè H. S., van Rijthoven A. W., Breedveld F. C., Dijkmans B. A. A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum. 1994 May;37(5):637–643. doi: 10.1002/art.1780370506. [DOI] [PubMed] [Google Scholar]
  23. Leung D. Y., Meissner H. C., Fulton D. R., Murray D. L., Kotzin B. L., Schlievert P. M. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4;342(8884):1385–1388. doi: 10.1016/0140-6736(93)92752-f. [DOI] [PubMed] [Google Scholar]
  24. Luqmani R. A., Bacon P. A., Moots R. J., Janssen B. A., Pall A., Emery P., Savage C., Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994 Nov;87(11):671–678. [PubMed] [Google Scholar]
  25. Mapp P. I., Walsh D. A., Garrett N. E., Kidd B. L., Cruwys S. C., Polak J. M., Blake D. R. Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis. 1994 Apr;53(4):240–246. doi: 10.1136/ard.53.4.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Marber M., Walker D., Yellon D. Ischaemic preconditioning. BMJ. 1994 Jan 1;308(6920):1–2. doi: 10.1136/bmj.308.6920.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murphy E. A., Bell A. L., Wojtulewski J., Brzeski M., Madhok R., Capell H. A. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis. BMJ. 1994 Nov 19;309(6965):1337–1338. doi: 10.1136/bmj.309.6965.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. No need for a dry run. Lancet. 1994 Jul 2;344(8914):1–2. [PubMed] [Google Scholar]
  29. Pascual E. Hyperuricemia and gout. Curr Opin Rheumatol. 1994 Jul;6(4):454–458. doi: 10.1097/00002281-199407000-00018. [DOI] [PubMed] [Google Scholar]
  30. Porter D. R., McInnes I., Hunter J., Capell H. A. Outcome of second line therapy in rheumatoid arthritis. Ann Rheum Dis. 1994 Dec;53(12):812–815. doi: 10.1136/ard.53.12.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pritchard M. H. Evidence for a hypothetical non-HLA susceptibility gene in rheumatoid arthritis. Br J Rheumatol. 1994 May;33(5):475–479. doi: 10.1093/rheumatology/33.5.475. [DOI] [PubMed] [Google Scholar]
  32. Pullar T., Capell H. A. A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis. 1985 Feb;44(2):134–140. doi: 10.1136/ard.44.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sambrook P. N. Osteoporosis in rheumatoid arthritis: what is the role of antirheumatic therapy? Lancet. 1994 Jul 2;344(8914):3–4. doi: 10.1016/s0140-6736(94)91040-5. [DOI] [PubMed] [Google Scholar]
  34. Sharpe M., Mayou R., Seagroatt V., Surawy C., Warwick H., Bulstrode C., Dawber R., Lane D. Why do doctors find some patients difficult to help? Q J Med. 1994 Mar;87(3):187–193. [PubMed] [Google Scholar]
  35. Trentham D. E., Dynesius-Trentham R. A., Orav E. J., Combitchi D., Lorenzo C., Sewell K. L., Hafler D. A., Weiner H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993 Sep 24;261(5129):1727–1730. doi: 10.1126/science.8378772. [DOI] [PubMed] [Google Scholar]
  36. Vischer T. L., Van Eden W. Oral desensitisation in rheumatoid arthritis. Ann Rheum Dis. 1994 Nov;53(11):708–710. doi: 10.1136/ard.53.11.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vreugdenhil G., Baltus C. A., van Eijk H. G., Swaak A. J. Anaemia of chronic disease: diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients. Br J Rheumatol. 1990 Apr;29(2):105–110. doi: 10.1093/rheumatology/29.2.105. [DOI] [PubMed] [Google Scholar]
  38. Waddell G. Simple low back pain: rest or active exercise? Ann Rheum Dis. 1993 May;52(5):317–319. doi: 10.1136/ard.52.5.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weinblatt M. E., Kaplan H., Germain B. F., Block S., Solomon S. D., Merriman R. C., Wolfe F., Wall B., Anderson L., Gall E. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum. 1994 Oct;37(10):1492–1498. doi: 10.1002/art.1780371013. [DOI] [PubMed] [Google Scholar]
  40. Winrow V. R., Winyard P. G., Morris C. J., Blake D. R. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull. 1993 Jul;49(3):506–522. doi: 10.1093/oxfordjournals.bmb.a072627. [DOI] [PubMed] [Google Scholar]
  41. Wordsworth B. P., Bell J. I. The immunogenetics of rheumatoid arthritis. Springer Semin Immunopathol. 1992;14(1):59–78. doi: 10.1007/BF00197132. [DOI] [PubMed] [Google Scholar]
  42. Wordsworth P., Pile K. Genetic modelling in rheumatoid arthritis: cat walk or tight rope? Br J Rheumatol. 1994 May;33(5):409–410. doi: 10.1093/rheumatology/33.5.409. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES